Background Patient activation-the knowledge, skills, and confidence to manage one's health
| INTRODUCTION
Currently, 15.5 million cancer survivors live in the United States; and the largest subpopulations of survivors are men with prostate cancer (45%) and women with breast cancer (44%). 1 After cancer treatment, patients are expected to navigate a complex, fragmented health care system that is inexperienced at meeting their long-term needs. 2 Proposed models of long-term care for cancer survivors involves collaboration between oncologists and primary care providers (PCPs), with an eventual tapering off of oncology care after the early phases of follow-up care are completed. 3, 4 Cancer is now understood as a chronic condition that requires patient's self-management well beyond the end of acute treatment. 5 Self-management during survivorship includes follow-up with oncology team and PCPs at recommended intervals, awareness of symptoms of recurrence, adapting physically and emotionally symptoms, and making necessary lifestyle adjustments to support recovery. 5 Chronic care models emphasize partnerships between health care providers and "informed, activated patients" for optimal patient outcomes. 6, 7 Patient activation is a modifiable characteristic and refers to the level of motivation, knowledge, skills, and confidence to manage one's own health. 8, 9 Increases in activation are associated with positive changes in general health and disease-specific self-management. 10, 11 While efforts
| Measures
Each patient completed a mailed, written, self-reported survey upon enrollment that assessed patient characteristics, clinical factors, and patient activation. The outcome of interest was patient activation, measured by the 13-item Patient Activation Measure (PAM), 20 with a modified response scale. Our response scale included "uncertain" as its midpoint (ie, strongly disagree, disagree, uncertain, agree, or strongly agree) compared to the original PAM scale which includes "not applicable" displayed outside of the 4-point range (ie, strongly disagree, disagree, agree, or strongly agree; NA). Our 5-point response scale was converted to a 4-point range (with 5 unique values with equal distance between them) so that scores would be consistent with the original response scale. Cronbach alpha for PAM with the modified response scale was 0.89. Mean score across the 13 items was used as the composite score, with higher scores indicating higher levels of patient activation. Table 1 .
Cancer site was associated with activation (P-value = .039), with breast survivors reporting slightly higher mean scores (M = 3.34, SD = 0.37) when compared to prostate survivors (M = 3.25, SD = 0.38) (see Table 2 ). Demographic factors were not significantly associated with activation in breast survivors. Yet, uncertainty about the future (P-value = .004) was related to activation, with breast survivors who "very often" had thoughts of uncertainty having the lowest mean activation scores (M = 3.17, SD = 0.48) compared to reported less frequent concerns of uncertainty. In prostate survivors, race (P-value = .048), marital status (P-value < .001), employment status (P-value = .004), and income (P-value = .050) were significantly associ- had the lowest activation (M = 3.07, SD = 0.38) (see Table 2 for Significant interactions between patients' perceptions of time spent with PCPs and income on patient activation were observed (see Table 3 ). The associations between time spent with a PCP on activation were significantly modified by household income in both prostate (P-value = .040) and breast survivors (P-value = .036). For prostate survivors, in the middle income (P-value = .013) and highest income (P-value = .002) groups there were significant effects on patient activation, while those in the lowest income group saw no such effects. Among prostate survivors in the high income group activation scores were relatively the same among those who agreed and disagreed that time spent with the PCP was adequate while there was an observed 
| CONCLUSIONS
This study aimed to describe the determinants of patient activation in breast and prostate cancer survivors to inform assessment and intervention development to support self-management during survivorship.
This study found that breast cancer survivors are on average, significantly more activated than prostate survivors. Further, unlike breast survivors, prostate survivors' activation scores were associated with several demographic characteristics such as race, marital status, employment, and income. There were some similarities among breast and prostate survivors, with psychosocial variables in both associated with lower activation [23] [24] [25] ; however, different variables were significant for each cancer site. In prostate survivors, frequent concerns about disease recurrence were associated with lower activation compared to those who worried less frequently. While in breast survivors, frequent worries about the uncertainty of the future was associated with lower activation compared to those who reported less worries about the uncertainty of their future. Clinically, the relationship between psychosocial factors and patient activation may be important to consider assessing and intervening appropriately.
A notable finding of this study is that for both breast and prostate survivors' perceptions of easy access to their providers (both PCPs and oncologists) were associated with activation. In chronic illness models, the relationship between providers and patients are seen as transactional, involving an interpersonal exchange. 26 This study's results are similar with research in chronically ill populations that have demonstrated that better access to physicians is associated with higher patient activation scores. 26 Physicians' communication skills, particularly listening skills and promoting exploration of patient issues during encounters have been found to enhance activation, because patients are more engaged and invested in the decisions made, which in turn improves patient adherence to physicians' recommendations. 27, 28 Future explorations of cancer survivors activation should extend the work of studies in other chronically ill populations, which have shown that patients' perceptions of time spent with physicians, clarity of explanations, and being treated fairly and with respect were associated with higher patient activation levels. 26 As cancer follow-up shifts into a chronic disease model of care
empirically tested interventions that target activation are needed 26 ; further, these may need to be tailored to the specific needs of subpopulations. Previous studies have shown that activation varies by how many and the types of chronic conditions a patient is managing; generally, patients who have multiple chronic illnesses also have lower levels of activation. 14 Consistent with the results of this study, patients with a cancer history generally reported higher activation levels on average. 14 Our present study found women survivors of breast cancer have higher average activation levels than male prostate survivors. To our knowledge, no previous studies have reported on differences between types of cancers; however, studies have reported significant effects for gender on activation in other chronically ill populations. In a nationally representative US sample, the overall adjusted scores of patient activation were significantly higher for adult females than males. 14 However, a different study assessing patient activation rates among racial and ethnic minorities in a low income setting found patient activation was significantly higher among men when compared to woman. 29 In the general population, the trends suggest that men engage in less preventive health seeking behaviors and this tends to be more pronounced among low-income men. [30] [31] [32] ; however, many prostate survivors navigate treatment decisions with ambiguous information, which have an impact on the long-term effects they experience. 34 Therefore, there may be different processes and consequences of care in these populations beyond gender alone that need to be considered.
Patient activation interventions may be promising to address health disparities in cancer survivors. Patients in lower socioeconomic groups tend to have lower levels of activation. 12, 14 Patients with lowest levels of activation also appear to be most responsive to interventions 8 , and several programs targeting other conditions have been effective at increasing activation over time. 19, [35] [36] [37] This is consistent with our study, for both breast and prostate survivors those in middle and the highest income groups who agreed most strongly that the PCP spent enough time with them reported the highest activation scores.
Patient activation intervention development may benefit from considering both the factors that impact provider-patient relationships and patient activation. Studies have shown that when patients with high and low activation scores are seen by the same clinician, those with higher scores report more positive experiences than those with lower activation scores, when controlling for sociodemographic factors and health status. 38 Additionally, less activated patients are less likely to have a usual source of care, even after controlling for socioeconomic and health status factors. 14 In cancer survivors, there is a focus on transitioning patient from acute care to follow-up care, which typically does not account for whether survivors have an established usual source of care.
This study provides a descriptive understanding the factors that are associated with patient activation among breast and prostate cancer survivors' treated in academic and community settings. There are several points to consider in developing future research to further investigate patient activation among cancer survivors. First, we used a regional sampling strategy, and cannot generalize these findings nationally. However, given the widespread application of patient activation across multiple chronic conditions adding patient activation into existing nationally representative datasets would help to develop a broader understanding of activation and its relationship to cancer follow-up as well as other clinical outcomes. In this study, the PAM measure we used varied from the traditional PAM because a modified response scale that included uncertain as its midpoint was how the data was collected. This may limit the direct comparability of scores reported in this study to those in other chronic disease populations where the original PAM response options and scoring were used. In future studies, using the traditional PAM would allow for direct comparison between cancer survivors and other chronically ill populations.
Additionally, the development and evaluation of interventions to improve patient activation and its impacts on care seeking and selfmanagement behaviors in cancer survivors could inform the development of evidence-based approaches to survivorship care.
